Biopharmaceutics is an open access journal that provides an advanced forum for the science and technology of pharmacology and biopharmaceutics. It deals with the study of chemical and physical properties of pharmaceuticals, their components and their activities in living organisms. Topics include pharmacokinetics, pharmacodynamics, pharmacogenetics, pharmacogenomics, and pharmaceutical formulation, toxicology.
A biopharmaceutical product, illegally known as a medical (al) biological or biological product, is any pharmaceutical product manufactured, extracted or semi-synthesized from biological sources. Differently synthesized pharmaceuticals, they include vaccines, blood, blood components, allergens, somatic cells, gene therapies, tissues, recombinant therapeutic proteins and medicis. Biologics can be composed of sugars, proteins or nucleic acids or complex combinations of these substances, or can be living cells or tissues. They (or their precursors or components) are isolated from living sources - human, animal, plant, fungal or microbial.
The terminology of biopharmaceuticals varies by group and entity, with different terms referring to different subsets of therapeutic products within the general biopharmaceutical category. Certain regulatory bodies use the terms biological drugs or therapeutic biological products to designate modified macromolecular products such as proteins and nucleic acid drugs, which are often extracted directly from a biological source. Specialty drugs, a recent classification of pharmaceuticals, are expensive drugs that are often biological . The European Medicines Agency uses the term advanced therapeutic drugs (ATMP) for human use that are "based on genes, cells or tissue engineering", including drugs from somatic cell therapy and tissue engineering tissues. drugs and combinations. In EMA contexts, the term advanced therapies refer to ATMP, although the term is rather non-specific outside of these contexts of tissue engineering drugs and their combinations